Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.30 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL872538 | 1.00 | CYP3A4 (0.30) | CYP3A4CYP2C8S1PR3CYP2C9 | |
| SCHEMBL10043098 | 0.97 | CYP2C9 (0.32) | CYP3A4CYP2C8S1PR3CYP2C9 | |
| SCHEMBL10043086 | 0.96 | CYP2C9 (0.31) | CYP3A4CYP2C8S1PR3CYP2C9 | |
| SCHEMBL10043100 | 0.96 | CYP3A4 (0.33) | CYP3A4CYP2C8S1PR3CYP2C9 | |
| SCHEMBL10043097 | 0.95 | CYP2C9 (0.35) | CYP3A4CYP2C8S1PR3CYP2C9 | |
| SCHEMBL10043196 | 0.94 | CYP3A4 (0.30) | CYP3A4CYP2C8S1PR3CYP2C9 | |
| SCHEMBL871571 | 0.94 | CYP3A4 (0.30) | CYP3A4CYP2C8S1PR3CYP2C9 | |
| SCHEMBL10043068 | 0.94 | CYP3A4 (0.30) | CYP3A4CYP2C8S1PR3CYP2C9 | |
| SCHEMBL10043099 | 0.93 | CYP3A4 (0.32) | CYP3A4CYP2C8S1PR3 | |
| SCHEMBL872993 | 0.93 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8470199-B2 | Five-ring liquid crystal compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2013-06-25 | — | — | US | disclosed |
| US-20120074355-A1 | FIVE-RING LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2012-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120074355-A1 | FIVE-RING LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | HTR3D, KIF23, CCND3 | CYP3A4 3528/4885CYP2C8 4099/4885S1PR3 578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.